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Abstract
Background: Q fever is a febrile illness caused by infection with the bacterium Coxiella 
burnetii. It is most often transmitted by inhalation of the bacteria after it is shed by infected 
livestock. Recent studies have found very high C. burnetii infection rates among marine mammals, 
but it is not known if shedding by marine mammals creates a risk of Q fever among humans. To 
better understand infection of humans with exposure to marine mammals, the prevalence of 
antibodies against C. burnetii in serum samples taken from Alaskan Native persons residing on the 
Pribilof Islands was evaluated. The Pribilof Islands support large populations of northern fur seals 
infected with C. burnetii that may increase the risk of exposure for island residents.
Methods: Serum testing for IgG antibodies against C. burnetii (phase I and phase II) was 
performed and demographic data was analyzed utilizing banked serum specimens drawn from 
island residents from 1980-2000.
Results: The overall seroprevalence rate was 11.6% (95% CI = 9.3-14.4%; 72/621). This is 
higher than the previously reported 3.1% (95% CI = 2.1-4.3%) seroprevalence for the U.S. 
population.
Conclusions: These results suggest that Alaskan Native persons may be at higher risk for 
exposure to C. burnetii than the general U.S. population, possibly due to proximity to large 
populations of infected marine mammals.
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Introduction
Q fever is a zoonotic disease caused by the globally distributed bacterium Coxiella burnetii 
(Maurin & Raoult, 1999). Elevated antibody titers against Phase I and Phase II antigenic 
phases correspond to chronic and acute forms of disease, respectively, as well as provide 
evidence of past infection (Fournier et al., 1998). Approximately half of infected persons 
develop clinical symptoms; the most commonly recognized forms of acute disease are a 
nonspecific flu-like illness, pneumonia and hepatitis (Anderson et al., 2013). Chronic Q 
fever is rare and most commonly presents as endocarditis in those with pre-existing valvular 
disease. Fatality rates in untreated chronic Q fever may exceed 65% and may occur years 
after the initial infection (Anderson et al., 2013, Maurin & Raoult, 1999).
Ruminants are considered the primary C. burnetii reservoir, with the most common impact 
on ruminant health being loss of pregnancy due to high levels of infection in the placenta 
(Angelakis & Raoult, 2010). Humans are typically infected by C. burnetii after inhalation of 
the bacteria in aerosolized secretions from ruminants. It is estimated that inhalation of <10 
organisms can initiate an infection (Tigertt et al., 1956). Other species, including wildlife, 
have also been associated with human infections (Fournier et al., 1998). Human exposure to 
marine mammals is emerging as a potential risk factor for Q fever infection. A case of Q 
fever endocarditis was reported in 2010 in a lifelong resident of Greenland with harbor or 
hooded seals implicated as a possible source of infection (Koch et al., 2010). Coxiella 
placental infection has been confirmed in a Pacific harbor seal in California by 
immunohistochemistry (Lapointe et al., 1999), a Steller sea lion in Washington by PCR 
(Kersh et al., 2010), and 109 (74.7%) of 146 placental tissue samples collected from a 
Northern fur seal rookery on St. Paul Island, Alaska by PCR (Duncan et al., 2012). In 
addition, of 218 Pacific harbor seals sampled in Washington, 50 (22.9%) tested positive for 
antibodies against C. burnetii (Kersh et al., 2012). The significance of these new findings 
and the relationship to human infection is poorly understood.
Canadian serosurveys have found 15% of trappers and 18% of Cree hunters to be positive 
for Q fever antibodies against C. burnetii (Levesque et al., 1995, Levesque et al., 2007). 
Because Q fever is often underdiagnosed due to its nonspecific clinical presentation and lack 
of readily available testing in some areas, the public health implications of this disease is 
unknown in the Bering Sea region. Persons residing on St. Paul and St. George, part of the 
Pribilof Islands in Alaska, may be particularly at risk for exposure to the pathogen based on 
proximity to seals and their rookeries and a high prevalence of C. burnetii found among 
animals at the seal breeding site on St. Paul. It is not known if the C. burnetii strains that 
infect marine mammals can be transmitted to humans and cause Q fever. The purpose of this 
investigation was to test stored serum samples from St. Paul and St. George residents for IgG 
antibodies to C. burnetii and examine Q fever seroprevalence related to demographics in this 
population.
Materials and Methods
The Alaska Area Specimen Bank (AASB) is a repository of more than 400,000 human 
samples stored from past research and investigations for use in studies to advance 
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understanding of Alaska Native people’s health (Parkinson et al., 2013). The AASB 
Oversight Committee manages the specimen bank. This group is made up of representatives 
from the Alaska Native Tribal Health Consortium (ANTHC), the Centers for Disease 
Control and Prevention (CDC) and Alaska Native Tribal Health Organizations (THO). We 
analyzed 621 serum samples collected from 621 individual St. George and St. Paul residents 
from 1980–2000 and stored at −20 to −30°C in the AASB. The AASB also provided 
demographic information including age, community, and gender. The study protocol was 
approved by the CDC and Alaska Area institutional review boards in compliance with all 
applicable Federal regulations governing the protection of human subjects.
An enzyme-linked immunosorbent assay (ELISA) was used to initially screen serum 
specimens for IgG Phase II antibody seropositivity (Verion-Serion, Wuerzburg, Germany) 
according to the manufacturer’s instructions with the exception that samples were diluted 
1:100. Any serum samples positive or equivocal by ELISA were then tested by 
immunofluorescence antibody assay (IFA) in order to obtain end point titers for IgG to both 
phase I and phase II C. burnetii antigens. Q fever seropositivity was defined as a phase I or 
phase II IgG titer ≥ 1:64 by IFA. The IFA test was performed by the method of Philip et al. 
(Philip et al., 1976) and adapted to C. burnetii using Nine Mile phase I and II antigens as 
described elsewhere (Peter et al., 1985).
Statistical analysis was performed using Epi Info version 3.3.2 (CDC, Atlanta, GA). The χ2 
test was used to compare the statistical significance of Q fever seroprevalence among 
groups. Age group differences were evaluated by the χ2 test for trend. Values of P < 0.05 
were considered significant in all statistical tests.
Results
The Pribilof Islands of St. Paul and St. George are located off the coast of Alaska in the 
Bering Sea (Figure 1). Stored serum samples previously collected from island residents were 
analyzed for this study. Among the 621 study participants, the male to female ratio was 
1.15:1 and the majority were residents of St. Paul (76%). The median age of the study 
population was 27 years (range, <1 year – 91 years). The largest age group was 21–40 years 
(43%; 266/621), while the 70+ year group included the lowest number of individuals (4%; 
26/621) (Table 1).
Out of the 621 study participants on St. Paul and St. George, 72 had a positive antibody titer 
to C. burnetii resulting in an overall seroprevalence of 11.6% (95% CI = 9.3–14.4%). 
Seventy-two persons aged 4–81 years had a positive Phase II IgG antibody titer to C. 
burnetii antigen of 1:64 or greater indicating past infection. Forty-nine of the 72 positive 
samples had a Phase II IgG titer of 1:64, but Phase II IgG titers of 1:1024 and 1:2048 were 
observed. Of the 72 seropositive persons, the majority (78%) were residents of St. Paul. Of 
151 St. George residents tested, 16 (10.6%; 95% CI 6.5–16.6%) had positive samples. Of 
470 St. Paul residents tested, 56 (11.9%; 95% CI 9.3–15.2%) had positive samples. There 
was no statistically significant difference in seropositivity between island residence or 
gender of participants. Seroprevalence for the total population increased with age and was 
highest among persons 60–69 years of age (22.9%) (Table 1). A linear t-test for trend for the 
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relationship between age and Q fever seropositivity was statistically significant (P =0.008). 
The majority of the samples were taken during the 1980’s with 148 samples from 1980–
1984, 420 samples from 1985–1989, 51 samples from 1990–1994, and 2 samples from 
1995–2000. However, there was no statistically significant relationship between year of 
specimen draw and seropositivity, analyzed either by individual year or by the 5-year groups 
described above.
Discussion
The Q fever seroprevalence among the residents of St. Paul and St. George during the years 
specimens were drawn (1980–2000) is higher than that of the general adult U.S. population, 
which was approximately 3% in samples taken during 2003–2004 (Anderson et al., 2009). 
However, the seroprevalence of Alaskan residents is unknown and may be higher than the 
general U.S. population and more closely approximate the findings from our study. A study 
that evaluated the seroprevalence among Alaska residents participating in outdoor activities 
that may increase the risk of exposure to zoonotic pathogens found that 8.3% of participants 
were positive for Phase II IgG antibodies (Miernyk et al., 2019). That study also found a 
seroprevalence of 11.7% among Alaska Native persons that participated in the study, similar 
to Pribilof Islands residents. These results suggest that Alaska Native persons have a greater 
risk of exposure to C. burnetii than non-native persons. The contribution of infected marine 
mammals to that increased risk remains to be determined. Also, the current serologic status 
of St. Paul and St. George residents is unknown as the most recent serum specimen tested in 
this study was ≥10 years old.
Although there is evidence that C. burnetii is present in the environment and wildlife of St. 
Paul (Duncan et al., 2012), it is unclear whether Q fever is a public health threat for current 
Pribilof Islands residents as we have no evidence of current symptomatic illness. At the time 
of the serosurvey, the St. Paul Health Center had not requested any diagnostic testing for Q 
fever for ill island residents. Due to the nonspecific presentation of Q fever disease, it has 
long been underreported and underdiagnosed. The results presented here support efforts by 
local health departments and Alaska Native tribal leaders to educate health care workers of 
the potential risk for Q fever infection and use of appropriate diagnostic testing and 
treatment methods for patients that present with compatible symptoms. The greatest risk of 
C. burnetii infection for Pribilof Island residents is likely to come from inhalation of dried 
and airborne C. burnetii derived from newborn Northern Fur Seals or placenta. Efforts to 
more clearly define the burden of C. burnetii infection and determine if there is a current 
health risk among St. Paul and St. George residents should be considered for future 
surveillance activities.
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Impacts:
• Q fever is a zoonotic disease caused by inhalation of the bacterium Coxiella 
burnetii
• Some Alaska Native persons live in close proximity to large populations of 
marine mammals that are infected with Coxiella burnetii, but it is not known 
if this creates a greater risk of Q fever among these populations
• The results of this study show that antibodies against Coxiella burnetii are 
more common among Alaska Native persons living near marine mammals 
than in the general population, suggesting that living near marine mammals 
exposes people to the bacteria
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Figure 1: 
Map of Alaska showing the location of the Pribilof Islands.
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TABLE 1.
Characteristics of St. Paul and St. George study participants
Characteristics Category Number of participants (%) Seroprevalence (%; 95% CI)
Age (years) 0-9 83 (13) 9/83 (10.8; 5.6-19.6)
10-19 105 (17) 5/105 (4.8; 1.8-10.9)
20-29 145 (23) 15/145 (10.3; 6.3-16.5)
30-39 121 (19) 13/121 (10.7; 6.3-17.6)
40-49 62 (10) 12/62 (19.4; 11.3-31.0)
50-59 46 (7) 8/46 (17.4; 8.8-31.0)
60-69 35 (6) 8/35 (22.9; 11.8-39.3)
70-79 19 (3) 1/19 (5.3; <0.0001-26.5)
≥80 5 (<1) 1/5 (20.0; 2.0-64.0)
Gender Male 332 (54) 38/332 (11.5; 8.4-15.4)
Female 289 (46) 34/289 (11.8; 8.5-16.0)
Residence St. Paul 470 (76) 56/470 (11.9; 9.3-15.2)
St. George 151 (24) 16/151 (10.6; 6.5-16.6)
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